Advantages of Drug Repurposing

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos Advantages of Drug Repurposing By Shawn Watson, Head of Research and Development What is Drug Repurposing? Drug repurposing became a topic of conversation this past year when existing therapeutics like the anti-malaria drug chloroquine/hydroxychloroquine and remdesivir, initially…

Read More

Navigating an Ever-Changing Landscape: the Role of a CFO in a Private Equity or Venture Capital Controlled Pharma Company

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos Navigating an Ever-Changing Landscape: the Role of a CFO in a Private Equity- or Venture Capital-Controlled Pharma Company By Kurt R. Nielsen, Ph.D., President and CEO, Pharmaceutics International, Inc (Pii) Executive Summary It can be lonely at…

Read More

Accelerating the Start of Your Outsourced Pharmaceutical Project—the Role of the Project Technical Review

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos Accelerating the Start of Your Outsourced Pharmaceutical Project—the Role of the Project Technical Review By Devan Patel and Vidhi Desai This is the second of two articles exploring best practices to streamline the underappreciated initial stages of…

Read More

Understanding Emergency Use Authorization (EUA)

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos Understanding Emergency Use Authorization (EUA) By Veeranna Lolla COVID-19 has spawned a new vocabulary that includes words like social distancing and zoom meetings. Given the impact of COVID-19 on our lives and our great desire for solutions,…

Read More

The Importance of Analytical R&D to Sterile Fill/Finish

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos The Importance of Analytical R&D To Sterile Fill-Finish By Irinia Prudnikova Sterile Fill-Finish is considered among the most critical steps in the parenteral production process, ensuring patient safety, maintaining pharmacological efficacy, and product quality. Drug product development…

Read More

The Value of Orphan Drug Designation

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos The Value of Orphan Drug Designation By Veeranna Lolla This year marked the 14th annual Rare Disease Day, which highlighted the reality that more than 90% of rare diseases still have no FDA-approved treatment. The orphan drug…

Read More

Accelerating the Start of Your Outsourced Pharmaceutical Project by Applying Thrust

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos Accelerating the Start of Your Outsourced Pharmaceutical Project by Applying Thrust By Devan Patel and Vidhi Desai This is the first of two articles exploring best practices to streamline the underappreciated initial stages of a relationship between…

Read More

Drug Development Executive Article: Pharmaceutics International, Inc: Getting Back to its Roots

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos Pharmaceutics International, Inc:Getting Back to its Roots Pharmaceutics International, Inc (Pii) has continuously evolved throughout its history as market and patient needs emerge and fade. There have been times when Pii developed and manufactured its own products…

Read More

Achieving Agility When Facing Uncertainty — Scaling Aseptic Pharmaceutical Production

BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBlogsCase StudiesMeet the ScientistPress ReleasesVideos Achieving Agility When Facing Uncertainty — Scaling Aseptic Pharmaceutical Production By Samuel Chia, Jay Shukla, and Dr. Bryan Braxton This past year has taught us that agile organizations will not only survive, but prosper, when faced with…

Read More

Oxygen Sensitive Drug Products

Oxygen is the second leading cause for quality degradation of pharmaceuticals, water being the first. While we typically think of packaging as the primary resource used to protect drugs from the negative effects of oxygen, there are things to consider during development and manufacturing to make sure excess oxygen isn’t simply packaged or bottled with the drug product.

Read More